Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle.

Brandenburg B, Stockl L, Gutzeit C, Roos M, Lupberger J, Schwartlander R, Gelderblom H, Sauer IM, Hofschneider PH, Hildt E.

Hepatology. 2005 Dec;42(6):1300-9.

PMID:
16317706
2.

Accumulation of 8-hydroxy-2'-deoxyguanosine adducts in HBx recombinant HepG2 cells and HBx transgenic mice.

Gehrke R, Brauchle MA, Reifenberg K, Hildt E, Gruetzner U, Schmitz V, Schlicht HJ, Hofschneider PH, Caselmann WH, Rabe C.

Digestion. 2004;70(2):117-26. Epub 2004 Sep 16.

PMID:
15375340
3.

Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression.

Stöckl L, Berting A, Malkowski B, Foerste R, Hofschneider PH, Hildt E.

Oncogene. 2003 May 1;22(17):2604-10.

PMID:
12730674
4.

The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice.

Hildt E, Munz B, Saher G, Reifenberg K, Hofschneider PH.

EMBO J. 2002 Feb 15;21(4):525-35.

5.

Site-specific mutation of the hepatitis B virus enhancer II B1 element: effect on virus transcription and replication.

Xie Y, Li M, Wang Y, Hofschneider PH, Weiss L.

J Gen Virol. 2001 Mar;82(Pt 3):531-5.

PMID:
11172094
6.

A novel negative cis-regulatory element on the hepatitis B virus S-(+)-strand.

Wagner M, Alt M, Hofschneider PH, Renner M.

J Gen Virol. 1999 Oct;80 ( Pt 10):2673-83.

PMID:
10573160
7.

The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways.

Hildt E, Hofschneider PH.

Recent Results Cancer Res. 1998;154:315-29. Review.

PMID:
10027012
8.

Isolation and molecular characterization of hepatitis B virus X-protein from a baculovirus expression system.

Urban S, Hildt E, Eckerskorn C, Sirma H, Kekulé A, Hofschneider PH.

Hepatology. 1997 Oct;26(4):1045-53.

PMID:
9328333
9.

Shock wave permeabilization as a new gene transfer method.

Lauer U, Bürgelt E, Squire Z, Messmer K, Hofschneider PH, Gregor M, Delius M.

Gene Ther. 1997 Jul;4(7):710-5.

10.

The hepatitis B virus MHBst167 protein is a pleiotropic transactivator mediating its effect via ubiquitous cellular transcription factors.

Caselmann WH, Renner M, Schlüter V, Hofschneider PH, Koshy R, Meyer M.

J Gen Virol. 1997 Jun;78 ( Pt 6):1487-95.

PMID:
9191947
11.
12.

The hepatitis B virus large surface protein (LHBs) is a transcriptional activator.

Hildt E, Saher G, Bruss V, Hofschneider PH.

Virology. 1996 Nov 1;225(1):235-9.

13.
14.

Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a well-established drug.

Weiss L, Hildt E, Hofschneider PH.

Antiviral Res. 1996 Aug;32(1):43-53.

PMID:
8863995
15.

Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease.

Brauchle M, Madlener M, Wagner AD, Angermeyer K, Lauer U, Hofschneider PH, Gregor M, Werner S.

Am J Pathol. 1996 Aug;149(2):521-9.

16.

Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro.

Luber B, Arnold N, Stürzl M, Höhne M, Schirmacher P, Lauer U, Wienberg J, Hofschneider PH, Kekulé AS.

Oncogene. 1996 Apr 18;12(8):1597-608.

PMID:
8622879
17.
19.

Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses.

de Verdugo UR, Selinka HC, Huber M, Kramer B, Kellermann J, Hofschneider PH, Kandolf R.

J Virol. 1995 Nov;69(11):6751-7.

20.

Round table discussion 'gene therapy and society'--summary and conclusions.

Hehlmann R, Odenbach E, Hofschneider PH, Strorhman R, Goldman J, Hausheer H, Takaku F.

Leukemia. 1995 Oct;9 Suppl 1:S7-8.

PMID:
7475318
21.

Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.

Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH.

Hepatology. 1995 Sep;22(3):707-17.

PMID:
7657273
22.

Transactivating function and expression of the x gene of hepatitis B virus.

Renner M, Haniel A, Bürgelt E, Hofschneider PH, Koch W.

J Hepatol. 1995 Jul;23(1):53-65.

PMID:
8530810
23.

Extracorporeal shock waves for gene therapy?

Delius M, Hofschneider PH, Lauer U, Messmer K.

Lancet. 1995 May 27;345(8961):1377. No abstract available.

PMID:
7752792
24.

Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis.

Stürzl M, Brandstetter H, Zietz C, Eisenburg B, Raivich G, Gearing DP, Brockmeyer NH, Hofschneider PH.

Oncogene. 1995 May 18;10(10):2007-16.

PMID:
7761101
25.
26.

[In memory of Prof. Dr. Dr. H.C. Adolf Butenandt].

Hofschneider PH.

Naturwissenschaften. 1995 Apr;82(4):157-9. German. No abstract available.

PMID:
7753202
27.

Characterization of a cardiac-selective and developmentally upregulated promoter in transgenic mice.

Franz WM, Brem G, Katus HA, Klingel K, Hofschneider PH, Kandolf R.

Cardioscience. 1994 Dec;5(4):235-43.

PMID:
7742482
28.

The function of KGF in morphogenesis of epithelium and reepithelialization of wounds.

Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, Williams LT.

Science. 1994 Nov 4;266(5186):819-22.

PMID:
7973639
29.

Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators.

Schlüter V, Meyer M, Hofschneider PH, Koshy R, Caselmann WH.

Oncogene. 1994 Nov;9(11):3335-44.

PMID:
7936659
30.

Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras.

McPhee F, Zell R, Reimann BY, Hofschneider PH, Kandolf R.

Virus Res. 1994 Nov;34(2):139-51.

PMID:
7531922
31.
32.

Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma: clinical, histological and cell biological evaluation.

Stürzl M, Zietz C, Eisenburg B, Goebel FD, Gillitzer R, Hofschneider PH, Bogner JR.

Res Virol. 1994 May-Aug;145(3-4):261-9.

PMID:
7800953
33.

The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.

Lauer U, Weiss L, Lipp M, Hofschneider PH, Kekulé AS.

Hepatology. 1994 Jan;19(1):23-31.

PMID:
8276360
34.

ER-localization and functional expression of the HBV transactivator MHBst.

Hildt E, Urban S, Lauer U, Hofschneider PH, Kekulé AS.

Oncogene. 1993 Dec;8(12):3359-67.

PMID:
8247538
35.

Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic mice.

Franz WM, Breves D, Klingel K, Brem G, Hofschneider PH, Kandolf R.

Circ Res. 1993 Oct;73(4):629-38.

PMID:
8370121
36.

The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C.

Luber B, Lauer U, Weiss L, Höhne M, Hofschneider PH, Kekulé AS.

Res Virol. 1993 Jul-Aug;144(4):311-21.

PMID:
8210715
37.

Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.

Kekulé AS, Lauer U, Weiss L, Luber B, Hofschneider PH.

Nature. 1993 Feb 25;361(6414):742-5.

PMID:
8441471
38.

Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells.

Caselmann WH, Meyer M, Scholz S, Hofschneider PH, Koshy R.

J Infect Dis. 1992 Nov;166(5):966-71.

PMID:
1328410
39.

Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts.

Heim A, Canu A, Kirschner P, Simon T, Mall G, Hofschneider PH, Kandolf R.

J Infect Dis. 1992 Nov;166(5):958-65.

PMID:
1328409
40.
41.

Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization.

Meyer M, Caselmann WH, Schlüter V, Schreck R, Hofschneider PH, Baeuerle PA.

EMBO J. 1992 Aug;11(8):2991-3001.

42.

Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance.

Stürzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH.

Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7046-50.

43.

A chromosome 17:7 translocation is associated with a hepatitis B virus DNA integration in human hepatocellular carcinoma DNA.

Meyer M, Wiedorn KH, Hofschneider PH, Koshy R, Caselmann WH.

Hepatology. 1992 Apr;15(4):665-71.

PMID:
1312986
44.

Trans-activation by hepatitis B virus X protein is mediated via a tumour promoter pathway.

Kekulé AS, Lauer U, Weiss L, Hofschneider PH, Koshy R.

Arch Virol Suppl. 1992;4:63-4.

PMID:
1450727
45.

Multicenter double-blind trial of interferon-gamma versus placebo in the treatment of rheumatoid arthritis.

Lemmel EM, Gaus W, Hofschneider PH.

Arthritis Rheum. 1991 Dec;34(12):1621-2. No abstract available.

PMID:
1747148
46.

Fibroblast growth factor 5 proto-oncogene is expressed in normal human fibroblasts and induced by serum growth factors.

Werner S, Roth WK, Bates B, Goldfarb M, Hofschneider PH.

Oncogene. 1991 Nov;6(11):2137-44.

PMID:
1658709
47.

Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization.

Hohenadl C, Klingel K, Mertsching J, Hofschneider PH, Kandolf R.

Mol Cell Probes. 1991 Feb;5(1):11-20.

PMID:
1850115
48.

Low mitogenic response to EGF and TGF-alpha: a characteristic feature of cultured Kaposi's sarcoma derived cells.

Werner S, Viehweger P, Hofschneider PH, Roth WK.

Oncogene. 1991 Jan;6(1):59-64.

PMID:
1992446
49.

Novel ribonucleic acid species in Eimeria nieschulzi are associated with RNA-dependent RNA polymerase activity.

Sepp T, Entzeroth R, Mertsching J, Hofschneider PH, Kandolf R.

Parasitol Res. 1991;77(7):581-4.

PMID:
1792227

Supplemental Content

Loading ...
Support Center